1 not yet recruiting. .
Follow Junjie Xu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness Observational study of 29 - gene - defined HCC subtypes and immunotherapy responsiveness correlation - Primary Hepatocellular Carcinoma | Not yet recruiting | Junjie Xu | 350 | 2025-08-01 | 2025-08-03 |
China (1)